title: Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management.
abstract: Inappropriate secretion of TSH was first described in 1960 in a patient with evidence of hyperthyroidism and expanded sella on imaging. It was later found that a type of pituitary adenoma that secretes TSH (thyrotropinoma) was the underlying cause. The objective of the present review article is to summarize data on the epidemiology, pathogenesis, diagnosis, and management of thyrotropinomas. The prevalence of thyrotropinomas is lower than that of other pituitary adenomas. Early diagnosis is now possible thanks to the availability of magnetic resonance imaging and sensitive laboratory assays. As a corollary, many patients now present earlier in the course of their disease and have smaller tumors at the time of diagnosis. Treatment also has evolved over time. Transsphenoidal surgery is still considered definitive therapy. Meanwhile, radiation therapy, including radiosurgery, is effective in achieving tumor control in the majority of patients. In the past, radiation therapy was used as second line treatment in patients with residual or recurrent tumor after surgery. However, the availability of somatostatin analogs, which can lead to normalization of thyroid function as well as shrink these tumors, has led to an increase in the role of medical therapy in patients who are not in remission after pituitary surgery. In addition, dopamine agonists have shown some efficacy in the management of these tumors. Better understanding of the molecular pathogenesis of thyrotropinomas may lead to rationally designed therapies for patients with thyrotropinomas.
authors.affiliation: Neuroendocrine Unit, Massachusetts General Hospital, Zero Emerson Place # 112, Boston, MA, 02114, USA.|Harvard Medical School, Boston, MA, USA.
authors.forename: Fatemeh G
authors.initials: FG
authors.lastname: Amlashi
authors.affiliation: Neuroendocrine Unit, Massachusetts General Hospital, Zero Emerson Place # 112, Boston, MA, 02114, USA. ntritos@partners.org.|Harvard Medical School, Boston, MA, USA. ntritos@partners.org.
authors.forename: Nicholas A
authors.initials: NA
authors.lastname: Tritos
mesh_terms: D000236:Adenoma / Q000175:diagnosis / Q000453:epidemiology / Q000378:metabolism* / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans; D006980:Hyperthyroidism / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D010911:Pituitary Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000378:metabolism* / Q000628:therapy; D013972:Thyrotropin / Q000378:metabolism*; D047368:Tumor Burden
chemical_list: D013972:Thyrotropin
keywords: Pituitary adenoma; TSH; Thyrotropinoma